Roche has put together a cancer immunotherapy research network and committed up to $100 million to support collaborations between the 21 academic centers.
Stallergenes Greer and Stanford University have teamed up to look for biomarkers of peanut oral immunotherapy efficacy.
Bristol-Myers Squibb has teamed up with Johns Hopkins University to research why patients respond and develop resistance to its PD-1 drug Opdivo.
Bristol-Myers Squibb has teamed with Infinity Pharmaceuticals to add another study to its burgeoning roster of combination trials featuring PD-1 drug Opdivo.
An audible sigh of relief was heard this morning that, at last, the U.S. 2016 election is over. In the end, in what was an oft-controversial, hot-tempered and…
The IPO raised the offer price and the number of shares sold with backing from new investors Pfizer and BB Biotech.
An IPO for Ra Pharmaceuticals has priced raising $92 million, while another for Myovant Sciences has commitments from Pfizer and BB Biotech.
A St. Louis, MO-based preclinical startup has nabbed a GSK partnership. The pair will focus on antibiotic-sparing drugs to treat and prevent urinary tract…
Merck is confident that its Keytruda will work well in combination with traditional chemotherapy. Up next are next-gen combos.
NantVentures has made an investment in microcap Australian biotech Benitec Biopharma.